The stimulus or the method applied in an experiment that triggers IT in the brain.

Method of PC by inducing either global or focal transient cerebral ischemia. When the PC stimulus is different than ischemia, PC will be named according to the nature of the trigger (e.g., hypoxic-PC, anesthetic-PC, chemical-PC). In the literature, sublethal or priming ischemia have been used as alternative terms to IPC. For subsequent ischemic insult given after PC, the term test ischemia is often used 67, among others (final, lethal, reference, or full ischemia). We will prefer to name the subsequent ischemic event as final ischemia.

Briefly, the protection from final ischemia provided by prior PC refers to as IT. Depending on the media used to study the phenomenon of IT, IT may refer to the cell, tissue, or organ's post-ischemic state wherein, due to previous PC exposure, the response to ischemia is different from one observed without previous PC. In this article therefore, PC and IT define two different (but related) entities and are not used interchangeably.

It is the consequence of both pre- and post-ischemic protective responses induced by PC 5; in other words, it is the resulting phenotype from both PC and final ischemia.

It determines the status of the cell, tissue, or organ exposed to PC that experiences changes triggered by PC, and it occurs before the application of final ischemia 5. Hence, the latent cerebroprotective phenotype differs from the ischemia-tolerant phenotype by the lack of exposure to final ischemia (Figure 1).

With the better understanding of the concept of neurovascular unit (i.e., the contribution of glial and vascular endothelial cells and their interactions with neurons in physiological and pathological conditions), researchers' attention shifted from neurons towards cerebrum. Hence, instead of "neuroprotection", we prefer to use "cerebroprotection", which covers not only neurons but all the cerebral cell populations experiencing IT. To interpret IT afforded on single cell type (hippocampal CA1 neurons in global ischemic models or type of cell slice used in vitro study), the protective effect provided by PC will be discussed as "protection".

Rat forebrain ischemia experiments necessitate the occlusion of both posterior and anterior blood circulation of the brain. Four-vessel occlusion was originally described by Pulsinelli et al. 12 as a two-stage procedure wherein first both vertebral arteries are permanently closed and the following day, both carotid arteries are occluded. The model has been modified later by the same authors 13 and others 14. In rats, delayed IT was provided by 3 15 and 5 min 16 of four-vessel occlusion to 6 to 20 min of final global ischemia 151617. Appropriate durations of PC and the interval between PC and final ischemia in this scenario have been studied by monitoring postischemic Hsp72 protein expression as a marker of IT 18. Neither 3, nor 8 min of IPC induced sufficient synthesis of Hsp72. Once PC was fixed to 4 to 5 min, the minimum 2 days of interval was required between PC and final ischemia.

This model, originally described by Smith et al. 19 in the rat, includes bilateral carotid artery occlusion and systemic hypotension induced by withdrawal of arterial blood. Compared to four-vessel occlusion, it is less invasive and more reproducible, as the depth of ischemia depends on hypotension, rather than on surgical attenuation of collateral perfusion 20. PC by 2 to 3 min of two-vessel occlusion induces delayed IT in rats to 5 to 10 min of final global ischemia 212223. Early IT was also achieved in this model 24.

The gerbil mostly lacks a functioning circle of Willis 25, a short period of bilateral occlusion of carotid arteries (3-5 min) therefore leads to severe damage in CA1 pyramidal neurons 2627. First introduced by Kitagawa et al. 3, PC by single 2-min bilateral carotid occlusion (or two times), 1 to 7 days before final ischemia in the gerbil brain has been a well-standardized method to study IT 282930. A disadvantage of the gerbil two-vessel occlusion model is that the severity of forebrain ischemia is highly influenced by the anatomical variations, which are not seldom 31. Here, we should note that thresholds for severity (i.e., duration of the bilateral carotid occlusion), differentiating the outcome as either PC or final insult, are in a narrow scale. To overcome this issue and ensure a better control over the ischemia severity, Abe and colleagues 7 provided a useful modification of the model. By monitoring depolarizations, they largely eliminated the variability of the ischemia and IT. This approach later was introduced in a rat global-global IT model using four-vessel occlusion 32.

This method, borrowed from its equivalent in gerbils, may induce reproducible striatal injury in mice 33. For a delayed IT paradigm, Wu et al. applied 6 min of two-vessel occlusion as PC and 18 min of bilateral carotid artery occlusion as final ischemia in C57BL/6 mice 34. As this strain is a common subject of transgenic technology, the model proved useful for investigating the molecular mechanisms of IT in gene-modified mice. In a such scenario, a much longer two-vessel occlusion period (20 min) has induced delayed IT 35.

Transient occlusion of the middle cerebral artery (MCA) by intraluminal insertion of a nylon monofilament, which was originally described by Koizumi et al. 36 and modified by others 37, is the most common model to induce focal cerebral ischemia in rats 38394041 and also available in mice 42434445. This method was introduced first time in a rat IT experiment, applying 10 min of transient MCA occlusion (tMCAO) as the PC stimulus and permanent MCAO as the final ischemia 46. Authors evaluated IT phenomenon with several reperfusion periods between IPC and final ischemia and showed that ischemic lesions involving both cortex and basal ganglia could be reduced when final ischemia was applied 1, 2, and 7 days after PC, but not 2, 6, and 12 hours or 14 and 21 days after PC. This model was applied successfully by others to obtain delayed IT 4748. Repeated brief transient ischemia regimen was also proved as a preconditioning paradigm inducing early IT in mice subjected to permanent focal ischemia 4950.

One 5152 or 3 times of 10 min transient focal cerebral ischemia protects from subsequent 120 min of tMCAO in rats 535455. Shorter durations (2 and 3 min) of tMCAO were severe enough to induce delayed IT, but did not provide early IT to transient ischemia 5657. Transient focal-focal IT paradigm induced IT also in mice and spontaneously hypertensive rats 5859. A recent mouse model of delayed-IT involves 2 periods of 5-min tMCAO as the PC method, against 90-min tMCAO applied in 3 days, but not in 2 or 4 days 6.

Brief global ischemia can protect from both subsequent transient and permanent focal ischemia 6061.

Exposure of neonatal rats to 8% oxygen for 3 hours provides cerebroprotection from a combined hypoxia/ischemia model 65 and also from both transient and permanent focal cerebral ischemia 6667. Varying hypoxia durations (1, 3, or 6 hours) result in similar extent of protection, but when the interval between hypoxia and final ischemia exceeds 72 hours, IT abolishes 67.

Hyperbaric oxygen was found protective from subsequent global ischemia in gerbils 68 and from permanent focal ischemia in SV129 mice 69, whereas it did not induce IT to transient focal ischemia in these mice 69. Rats were protected from transient ischemia by hyperbaric oxygen PC, but they were not protected from permanent ischemia 70. Repeated hyperbaric oxygen application seems to induce IT to global ischemia in the rat brain for a shorter period than 72 h 71.

In rodent experiments, indirect brain temperature can be measured with a probe placed under the temporal muscle and can be maintained at a desired level by heaters allowing feedback adjustments. Chopp et al. first time observed the PC effect of hyperthermia in rats subjected to global ischemia 72. Hyperthermia was protected as well neonatal rats from hypoxia/ischemia 73.

The hypothermic-PC has been described in a rat model of focal transient ischemia 74 and later was studied systematically in order to define the optimal depth, duration, and the method of application (global versus focal hypothermia) 75. The extent of protection was dependent on the depth and duration of the hypothermia, focal cooling being as effective as systemic cooling. Although the deeper the hypothermia, the bigger the IT response was, mild to moderate levels of hypothermia, which are safe in humans 76, were efficient as well. This may encourage clinicians to test hypothermia as a preconditioning strategy, for instance before vascular surgical interventions with high risk of ischemic events.

Leão's spreading depression is a generalized and stereotyped response of the cerebral cortex to a variety of noxious stimuli and is characterized by a slowly moving, transient, and reversible depression of cortical electrical activity that spreads like ripples in a pond; these waves, from the site of onset, spread usually to the whole cortex of the ipsilateral brain hemisphere with a speed of 2 to 5 mm per minute 77. Topical application of high concentration of potassium chloride onto the cortex induces spreading depression that repetitively extends from the sites of increased extracellular potassium concentration with a frequency of approximately 7/100 min 78. This method has been an effective PC trigger in both global 79 and focal ischemia models in rats 808182. IT induced by spreading depression seems to develop in a delayed manner (in 3-6 days) 8384 and was shown to persist up to 15 days 85.

Limb ischemia by bilateral femoral artery occlusion protects rat from either global ischemia 86 or transient focal ischemia 87. It can be applied as well repeatedly (5-10 min for 3 times, with 10 minutes intervals in between). This PC approach was successfully tested in humans to induce IT in the heart 88. Mesenteric artery occlusion for 15 min was protective against bilateral carotid occlusion in mice 89.

This is the most extensively studied chemical PC agent, which inhibits oxidative phosphorylation. Intraperitoneal administration of 3-NPA, 72 hours before transient focal ischemia, is a well-established PC trigger for rats 90919293. Regarding the efficacy of 3-NPA as a PC trigger, some contradictory results came from gerbil models of global ischemia 949596, but these may be related to the doses used 97.

LPS is a cell-wall component of gram-negative bacteria. A small dose provides IT in the brain. This has been proven in a number of experiments including both transient 9899 and permanent 100101 focal ischemia models in rats, as well as in a mouse model of transient focal ischemia 102. With higher doses no PC effect occurs 98.

Potential protective effects of anesthetics from an ischemic insult have been known for long time 2 and were well-studied in experimental stroke models as a cerebroprotective strategy (for reviews see 103104105). Among anesthetics, isoflurane is the most commonly used volatile anesthetic in IT experiments. Different concentrations (0.5-4%) and varying durations (15 min-3 hours) of isoflurane inhalation have been efficient to induce both early 106107 and delayed IT in vivo 108109 and in vitro models 110111. Among other anesthetics, xenon 112, halothane 113, and sevoflurane 114 may also induce IT in animal models. Anestetic-PC has been proven a promising PC method for heart in humans 115.

Several clinically available drugs, including estrogen 116, erythromycin 117118, and erythropoietin 119120, are capable of inducing IT in animal models. Acetylsalicylic acid 121 and kanamycin 122 were effective as PC agents in vitro.

Repeated electroacupuncture 123124, electrical stimulation of cerebellar fastigial nucleus 125, and dietary restriction 126 protected rats from subsequent transient focal ischemia. In global ischemia rat models, repetitive transcranial magnetic stimulation 127, electroconvulsive shock 128, kainite-induced epileptic seizures 129, and sleep deprivation 130 all have served as PC stimuli.

Neuronal cell culture systems provide an ideal microenvironment to study PC, because they lack a vascular compartment and the environment is easily controlled for confounding factors (e.g., see the fascinating work by Gonzalez-Zulueta et al. 131). In vitro modeling for ischemia consists of oxygen and glucose deprivation (OGD) in the culture medium, and perhaps the most widely used method is the one described by Goldberg and Choi 132133. This model includes the transfer of neocortical cell cultures for several hours to an anaerobic chamber containing a gas mixture of 5% CO2, 10%H2, and 85%N2 (oxygen deprivation), followed by application of a deoxygenated glucose-free medium (glucose deprivation). Organotypic hippocampal slice cultures offer an attractive alternative method, because many aspects of in vivo ischemia, such as delayed death of CA1 neurons and selective vulnerability in response to OGD, can be addressed 134. Hassen et al. has introduced a new model of IT by isolating hippocampal slices from young rats, to abolish age-dependent resistance to ischemic injury 135. Also mixed neocortical cultures are available to study IT in vitro 136.

Determining the extent of injury after focal ischemia is relatively simpler than after global ischemia. For this purpose, traditional histological staining techniques, such as hematoxylin-eosine and 2% solution of 2,3,5-triphenyltetrazolium chloride, are often used. Digital camera-based image analysis systems enable lesion area and volume calculations. Ischemic lesion volume is calculated preferably with the correction of edema effect 3839139140. In IT experiments, reduction in lesion volume due to PC (lesion size in the näive brain -- lesion size in the preconditioned brain) can be calculated as a percent ratio to the lesion size in the näive brain (Table 2). In global ischemia models, ischemic damage is assessed in hippocampal sections stained with toluidine blue 141, cresyl violet 3494, or thionin 142 by counting CA1 neurons, which are highly susceptible to global ischemia and easy to quantify due to their laminar distribution and large size 138. Protection due to PC can be reported as the percentage of preserved healthy hippocampal CA1 neurons or number of viable CA1 neurons 730129. In vitro models of IT use cellular injury assessments, such as lactate dehydrogenase assay 111143.

Gross measures of sensorimotor abilities are available for rodents 37144, and were introduced in IT experiments 464797107. However, in these species, gross sensorimotor deficits tend to recover rapidly. That is, more complex tests are needed, especially if outcome is assessed in long-term. A number of somatosensory tests (e.g. limb placing, beam walking, grid walking, rotarod) are available to apply in focal ischemia rat models 145. In global ischemia models, tests of learning ability, and working and reference memory are particularly useful 138146.

MRI technology allows for temporal and spatial monitoring of ischemic lesion and enables to conduct longitudinal studies 147148149150151. Besides requiring anesthesia, MRI is risk-free for experimental animals. First MRI-based lesion evaluation in an experimental IT study was reported by Mullins et al. 152. In a delayed IT model (focal--focal ischemia), rats were imaged 24 and 72 hours after final ischemia. Interestingly, lesion reduction due to PC was greater at 72 hours (70%) compared to that at 24 hours (53%). Authors concluded that 24 hours post-ischemia, which is a common time-point for lesion evaluation in experimental stroke studies 153154155, may not be the best time-point for experimental IT studies. Furuya et al., imaged rats serially (at 6 and 24 hours and 4, 7, and 14 days), following a delayed IT paradigm (LPC-PC--focal ischemia) 156. They evaluated whether decreased lesion size due to PC would increase in long-term. No delayed lesion progression was found.

Immmunohistochemistry is widely applied in IT research and serves to evaluate tissue alterations by means of antigen-antibody interactions. In situ hybridization and Western blotting techniques are applied to examine the effect of PC on the investigated protein's mRNA expression and abundance 141. DNA microarray technology, which allows quantification and differential expression of thousands of genes simultaneously, has been used to investigate global changes occurring between ischemia-tolerant and näive brains (see below "genomic reprogramming"). Real-time PCR can be used for confirmation of the selected genes, which found upregulated by microarray analysis 157; proteomics may provide supplemental insights 158. Alterations in neurotransmitter receptor density can be evaluated by quantitative in vitro receptor autoradiography 159160. Autoradiographical methods may show changes in the global protein status 29161.

Showing attenuation or abolishment of IT by pharmacological inhibition of a molecule before or after PC stimulus proves a robust approach. With this approach, necessary or mandatory components of IT can be explored 162163. Complementary information may come from genetically modified animals by proving abolishment of IT in mutants lacking a functional molecule or protein and showing reestablishment of IT in rescue experiments 164. Maintenance of IT, despite pharmacological inhibition of a molecule of interest or despite the lack of this molecule in the mutant mouse, may rule out the hypothetic causative role for the investigated molecule in the acquisition of IT 3584163. However, it should be noted that, the main effectors of IT can be model- or trigger-specific that, for instance, a specific molecule proven mandatory for hypoxia-induced IT in the rat brain 165 may not necessarily be required in OGD-induced IT in vitro 166.

Among several transcription factors sensitive to regulation by hypoxia/ischemia, HIF isoforms have gained the most experimental support 5. HIF-1 proteins are increased in the brain in the setting of hypoxia resistance 170 and hypoxic PC 67. Pharmacological activators of HIF-1 (deferoxamine or cobalt chloride) promote PC in hypoxia/ischemia model in neonatal rats 170. Over the past decade, the signalling pathways involved in HIF-1 activation have been deciphered in detail 171. Briefly, hypoxia stabilizes alfa subunit of HIF-1, which enters the nucleus in a dimerized form and results in the induction of HIF target genes. Several HIF target genes contribute protection from ischemia 67172173, and their products involve in wide range of adaptive and pro-survival events, including cellular metabolism, proliferation, vascularization, iron homeostasis, and glucose metabolism 5133.

The role of protein kinase C in mediating stroke injury has been reviewed recently 174. There are 10 isozymes in the PKC family. Previously, PKC was thought not to have a role in IT phenomenon, because blockage of PKC did not prevent IT 175, and PKC activation did not induce IT 176. However, accumulating data suggest opposite roles for different PKC isozymes in the brain: γPKC contributes in ischemic cell death in organotypic hippocampal cell cultures, and NMDA triggered IT models require εPKC translocation 177. Even though non-selective activation of PKC does not induce IT, specific εPKC activation leads to IT 143177. It seems that adenosine-mediated activation of εPKC and subsequent signal transduction pathways through MAPK-K, ERK 178, and cyclooxygenase-2 induction are involved in IT 143.

Exogenous application of NMDA or glutamate alone suffice to induce ischemia resistance in cell cultures, and NMDA receptor blockade during preconditioning eliminates IT both in vitro 179 and in vivo 180181. Specific AMPA or kainate receptor blockade do not eliminate or only partially attenuates IT 131180. Contradictory findings exist, however 136182. In gerbils, IPC increased inhibitory γ-amino butyric acid A (GABA_A) receptor binding in hippocampus, whereas final ischemia did not 160. Moreover, microdialysis experiments revealed a temporary increase in GABA release in preconditioned rat hippocampus early after final ischemia, with a decrease in glutamate concentration 21. Thus, anti-excitotoxic mechanism induced in ischemia-tolerant state in global ischemia models involve a shift between inhibitory and excitatory hippocampal neurotransmission. In vitro, GABA_B activation operates as a PC trigger 21, but not GABA_A activation 21183. Regarding the role of Ca²⁺ in IT, it seems not always mandatory 184, but chelation of Ca²⁺ before and during both OGD- and NMDA-PC prevents IT in vitro 177.

Adenosine, an ischemia-induced degradation product of ATP, activates A₁ receptors, which leads to a cascade of signaling events including K_ATPchannels. This cascade results in increased resistance to subsequent ischemic damage 185. The general role of K_ATP channels, which are named for the inhibitory effect of ATP reducing channel opening probability, is to set membrane potential according to its metabolic state by sensing intracellular nucleotide concentrations 186. Plasma membrane K_ATP channels are found widely throughout the brain 186. The mandatory role of K_ATP channels for acquisition of IT was demonstrated in a rat delayed IT model (global-global) 187 and in vitro 188. Interestingly, early IT is also blocked by pharmacological inhibition of K_ATP channels in vitro 176. Opening of K_ATP channels is thought to relate to adenosine A1 receptor activation. Both specific and nonspecific adenosine A1 receptor antagonists attenuate or cancel the IT phenomenon 187189190. However, SUR1-containing K_ATP channels seem not to be involved in IPC 35 and in spreading depression-PC model in rats and inhibition of K_ATP channels did not block IT 191. Some authors emphasize a more pronounced role for mitochondrial K_ATP channel in IT 169190.

NO is one of the most extensively studied molecules in IT experiments (for reviews see 192193). Data suggest that generation of NO is crucial for the induction of IT, as a dependence on endothelial NO synthase (eNOS), but not on the neuronal NOS (nNOS) in newborn rats subjected to hypoxic-PC 165. Whereas, nNOS was required to induce tolerance in vitro 166. OGD tolerance in cortical cell cultures occurred via the activation of the Ras/extracellular signal-regulated kinase cascade by NO 131. Atochin's early IT model proved an indispensable role for both eNOS and nNOS 50. Puisieux et al. used a delayed IT (focal-focal) model in adult rats and showed no effect of NOS blockade on IT, but when the PC stimulus was LPS, IT was abolished by NOS inhibition 194. Inducible NOS (iNOS) lacking mice experience no IT 164 and iNOS inhibition may nullify delayed IT to permanent focal ischemia, that otherwise follows isoflurane- or halotane-PC 113.

Interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) are implicated in IT induction: both cytokines are found increased in ischemic-tolerant state, both act as PC trigger when administered systemically, and their inhibition or lack significantly attenuate or block IT 195196197198. Pradillo et. al. explored the involvement of the TNF-α/nuclear factor-κB (NF-κB) signal transduction pathway in IT 48. This pathway includes at least 131 interactors 199. Activation of NF-κB is involved in IT in several models 200201, likely via the induction of neuroprotective gene products, such as manganese superoxide dismutase and Bcl-2 9. Preconditioning with ligands of toll-like receptors 4 and 9 may alter innate inflammatory responses to ischemia by causing an initial activation of inflammatory mediators followed by a burst of inflammation inhibitors 202.

PC blocks enhanced phosphorylation occurring after ischemia 9. On the other hand, phosphorylation of transcriptional factors can induce long-term changes by regulating the expression of genes. IT is also characterized by reduced apoptosis 5142. Phosphaphatidylinositol 3-kinase/Akt pathway seems to act in two ways: 1) in relation to anti-apoptotic mechanisms and 2) by activating NFkB. In vitro, p21 Ras is required and sufficient to induce IT and Ras/Erk pathway is activated through NMDA receptor and NO production 131. However, increasing evidences support the existence of a link between Akt activation and anti-apoptosis in IT 157203204205, perhaps more persistently in penumbral regions in focal IT models 206. Anti-apoptotic mechanisms induced by PC are several: induction of Bcl-2, reductions in caspase-3 synthesis and p-53 activation, and reductions in mitochondrial cytochrome c 9185.

With the contribution of DNA microarray analysis method to IT research, we gained a better understanding of the preconditioned brain on the genetic level. In 2003, Stenzel-Poore and colleagues published a study, a cornerstone in the field, which introduced the concept of "genomic reprogramming" defining the altered transcriptional response of the ischemia-tolerant brain 207. Followed by others 208209, profiled the genetics of IT induced by IPC in rats were profiled. In the setting of IT, overall transcriptional response to injury was found altered as downregulation, which was strikingly different from that in the naïve brain's postischemic transcriptome. Suppression of gene expression in the ischemia-tolerant state was not simply the lack of response to injurious insult, but rather a reprogramming of the genetic response to ischemia 210. Most of the genes suppressed are involved in the pathways that regulate metabolism, molecular transport, or cell-cycle control. Genomic transcriptional profile shows a substantial difference also between latent cerebroprotective and ischemia-tolerant states. None but one of the differentially regulated genes compared to healthy hemisphere are in common 208; however, in both states, overall response is downregulation of genes involved in metabolism and transport/synaptic transmission. Using GeneChip analysis, Dhodda et al. evaluated temporal changes in gene expression after IPC in spontaneously hypertensive rats 158. At the time-points studied (3, 6, 12, 24, and 72 h after PC), overall 40 transcripts were found up-regulated, among which 30 transcripts were overexpressed at all time-points, and the six HSP70 transcripts showed the highest increase. Other major families of transcripts, which were upregulated during PC, were those that control signal transduction, transcription, ionic homeostasis, and plasticity. Moreover, transcripts that showed upregulation after ischemia in näive brains were not found upregulated in ischemia-tolerant brains 158.

Gene expression response to hypoxic-PC was also studied 173. As early as 1 hour after hypoxia, but at a greater extent at 6 hours, expression of many genes, which are regulated by HIF-1, were increased. Compared to näive ischemic brains, in the ischemia-tolerant brains preconditioned with hypoxia, several genes were differentially upregulated. Genes with decreased expression in näive ischemic brains were no longer or only to a small degree underexpressed in ischemia-tolerant brains.

Genetic response to hyperbaric oxygen-PC was studied in the rat, in the latent cerebroprotective state (at 6, 12, 24 after PC) 71. Most of the differential regulations, including overexpression of genes and proteins related to neurotrophin and inflammatory-immune system, occurred around 12 and 24 hours. Genetic reprogramming was described as well for IT induced by erythromycin 118.

In vivo models demonstrating early IT in the brain are limited: global-global model in the rat 24, and focal-focal model both in the rat 211, and mouse 4950, and anesthetic-PC against focal permanent ischemia in the rat 113.

The molecular mediators of early IT are little known. Changes in membrane channel activity and posttranslational modifications of existing proteins are among the few, which are well-described. Roles for adenosine receptor in vivo 211 and for K_ATP channel in vitro were also explored 176. Several immediate-early genes (c-fos, c-jun), growth factors (brain-derived neurotrophic factor, nerve growth factor), and heat shock protein 70 were overexpressed during early latent ischemia-tolerant state 212. According to Kariko et al. 213, during early tolerance, production of proinflammatory cytokines are suppressed, whereas in delayed tolerance, production of the very same cytokines are induced.

Experimental data amounted for the last 20 years clearly demonstrated that IT can be afforded in animals by miscellaneous PC triggers. Thus, one can both easily and reasonably make the following assumption: diverse PC are sharing a common or overlapping pathway. As discussed above, a number of effector mechanisms confer ischemia-tolerant phenotype, and recently, genetic reprogramming was proposed as the underlying common process set into motion by these mechanisms 207208. Below, we will have a closer look to studies comparing the mechanistic or molecular features of IT triggered by different PC stimuli.

IPC versus LPS-PC was compared in a transient ischemia rat model and found inducing similar degree of protection (35% reduction in infarct volume) 194. An interesting finding was that NO synthase inhibition abolished the protective effect of LPS, but not of IPC. IPC induced the expression of heat shock protein 70 in the cerebral cortex, but LPS did not. Recently, ischemia-tolerant phenotypes induced by two well-known preconditioning stimuli -LPS and transient focal ischemia- have been evaluated from the genetic aspect 209. Authors disclosed that a substantial subset of regulated genes were unique to each PC stimulus. In case of IPC, mainly metabolism and channel/transport-related genes were suppressed; whereas, LPS-PC induced expression of pro-inflammatory molecules and suppressed those genes related to deleterious inflammatory reactions. However, suppression of Toll-like receptor-mediated inflammation is a common mechanism triggered by both PC triggers 213. Another comparative study of different PC stimuli (IPC and chemical PC with 3-NPA) addressed cytokine mRNA expression after final ischemia 214. Both PC strategies exerted very similar effects on proinflammatory and cytotoxic cytokine expressions. Later, same authors studied the expression of nerve growth factor separately with IPC and 3-NPA-PC paradigms 215. Neither trigger showed any effect on nerve growth factor expression, which in another study was found increased by PC with brief global ischemia in both early and delayed IT 212.

In focal-global IT paradigm, PC may confer IT in neurons outside the primary area subjected to IPC that is in proximity, but not in the further regions such as contralateral hippocampus 62. Similar IT paradigm in rats resulted in bilateral protection of hippocampi, however 63. A functional direct pathway from the entorhinal cortex to both hippocampi was suggested to reflect the changes afforded by IPC to both hemispheres 63. In the global-global IT paradigm, c-fos expression during the tolerant state was found specific to the cell type 216, which may explain selectivity of IT induction to certain brain areas.

Prass et al. studied the confounding effects of strain and reperfusion on the IT phenomenon 69. Hyperbaric oxygen was applied as PC stimulus to two common background strains for knockout mice, SV129 and C57BL/6. Final ischemia was either permanent or transient focal ischemia. In SV129 mice, PC induced tolerance to permanent ischemia but not to transient ischemia. In C57BL/6 mice, IT did not occur at all. Consequently, questions to answer with further study are: 1. For what reasons the very same trigger induced IT in a strain but not in another, and 2) Can reperfusion nullify the protection afforded by PC?

Female rats sustain smaller infarcts after MCAO than males 217 and estrogen is neuroprotective in ovariectomized females and in males subjected to ischemic stroke 218. Data from heart IT experiments show a clear gender-dependency of the IT phenomenon 219220, this issue seems valid also in cerebral IT. Estrogen provided IT in a model of hippocampal organotypic slice culture, which was generated from neonatal female rats 116, and isoflurane induced IT only in male mice and increased the infarction in young female mice 221.

IT phenomenon is preserved in aged animals 222, but may not be as effective as it is in young animals. This aspect was tested with a global-global IT paradigm applied in 4- and 24-month-old rats 223. The degree of protection due to PC was significantly diminished in aged rats compared to young rats. A retrospective clinical study indicated that IT may not be occurring in the elderly, aged around 75 224.

Cumulative injurious effect of repeated cerebral ischemia is a well-known phenomenon. For example, three periods of 5-min forebrain ischemia, induced at 1-hour intervals, result in more extensive brain injury than one single episode of 15-min ischemia in gerbils 225. However, if PC insults are applied repeatedly, a larger IT response may be gained. This was tested in a mice model of early IT, in which animals underwent either single or 3 episodes of 5-min focal cerebral ischemia, 30 min before permanent ischemia 49. Only repeated insults conferred IT, the single brief ischemia was insufficient to induce IT. Similarly, a single episode of 2 min OGD is under the threshold to act as a PC stimulus, but four times repeated 2 min of OGD show a cumulative effect and protects from subsequent injurious insult 226. Hyperbaric oxygen-PC, when applied singly or repeatedly, provide similar degree of protection from transient focal ischemia (63% vs 73% lesion reduction) 227, perhaps this is the maximum affordable protection by hyperbaric oxygen. In a clinical study however, anesthetic-PC with a single application induced no IT in the heart, whereas repeated application did 115. In the pig heart, PC by repetitive ischemic insults was shown to induce a different set of genetic regulations from those induced with PC with single ischemic episode 228. A corresponding study in cerebral IT is needed.

Although PC is defined as a sublethal stimulus, which per se causes no injury, several studies used relatively severe focal ischemia as the PC trigger and were able to induce IT, despite the injurious nature of the PC itself 6364190. As pointed out by Sommer 137, with extended follow-up after the PC insult, some injury or structural changes can be detected. Therefore, it is suggested that PC is postponing these changes 137. If that holds true, in the long-term, näive ischemic brains and IT experienced brains may have similar outcomes. This issue is discussed next.

Early IT is a short-lasting phenomenon, its protection vanishes around 7 days 24. In delayed IT models, protection lasts longer and tends to decline after 30-60 days. Ohno et al. applied a global-global IT model to rats 229 and showed that improvement in learning and memory due to IPC was preserved up to 3 weeks. Protective effects of spreading depression-PC and LPS-PC sustained up to 14 days 84156. Ma et al. found a sustained improvement in neurological scores up to 30 days in xenon-preconditioned neonatal mice subjected to global ischemia 112, a similar finding was reported with a focal-focal IT model in rats 51. In global-global IT models, histological protection is longer preserved in rats (up to 90 days) than in gerbils (up to 60 days) 3032222230. Optimizing time interval between PC and final ischemia, together with the optimization of the PC stimulus (single or repetitive application) and the severity of final ischemic insult, may result in long-term preservation of protection achieved by PC 32, on which increased neurogenesis after PC 231 may have a potential role.